🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for AIRE Deficiency

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata NCT05398809Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Ruxolitinib Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis NCT07202598Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Emapalumab Natural History of Individuals With Immune System Problems That Lead to Fungal Infections NCT01386437n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies NCT06941584n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Test for AQP4, AChR, LGI1, and CASPR2 autoantibodies using cell-based assay, AIRE single gene sequencing, Molecular typ…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy